The use of Bevacizumab in advanced ovarian cancer

被引:0
|
作者
Lobo, D. [1 ]
Rashmi, J. [1 ]
Jamey, M. [1 ]
机构
[1] Ipswich Hosp NHS Trust, Ipswich, Suffolk, England
关键词
D O I
10.1016/j.clon.2017.04.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S4 / S4
页数:1
相关论文
共 50 条
  • [41] Intraperitoneal chemotherapy without bevacizumab versus intravenous chemotherapy plus bevacizumab as frontline therapy in advanced ovarian cancer
    Ting, Wan Hua Stella
    Wang, Hsiao-Feng
    Chen, Hui-Hua
    Sun, Hsu-Dong
    Wei, Ming-Chow
    Hsiao, Sheng-Mou
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A205 - A206
  • [42] Bevacizumab in advanced cervical cancer
    Vlachostergios, P. J.
    Papandreou, C. N.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (10): : 935 - 935
  • [43] Bevacizumab for advanced breast cancer
    Goldfarb, Shari B.
    Traina, Tiffany A.
    Dickler, Maura N.
    WOMENS HEALTH, 2010, 6 (01) : 17 - 25
  • [44] Bevacizumab with Chemotherapy as a First-Line Treatment for Advanced Ovarian Cancer in a Serbian Cohort
    Conic, Irena
    Nedovic, Bojan
    Stojnev, Slavica
    Todorovska, Ilinka
    Dimitrijevic, Aleksandra
    Krstic, Miljan
    Djordjevic, Ivana
    Djordjevic, Biljana
    MEDICINA-LITHUANIA, 2022, 58 (05):
  • [45] Bevacizumab for advanced cervical cancer
    Sharma, Sharan
    LANCET ONCOLOGY, 2014, 15 (04): : E155 - E155
  • [46] Bevacizumab in advanced cervical cancer
    P. J. Vlachostergios
    C. N. Papandreou
    Clinical and Translational Oncology, 2014, 16 : 935 - 935
  • [47] Bevacizumab, paclitaxel and carboplatin for advanced ovarian cancer: low risk of gastrointestinal and cardiovascular toxicity
    Abaid, L. N.
    Lopez, K. L.
    Micha, J. P.
    Rettenmaier, M. A.
    Brown, J. V., III
    Goldstein, B. H.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2010, 31 (03) : 308 - 311
  • [48] Bevacizumab in advanced endometrial cancer
    Rubinstein, Maria M.
    Dickinson, Shannan
    Narayan, Priyanka
    Zhou, Qin
    Iasonos, Alexia
    Ma, Weining
    Lakhman, Yulia
    Makker, Vicky
    GYNECOLOGIC ONCOLOGY, 2021, 161 (03) : 720 - 726
  • [49] Bevacizumab for advanced breast cancer
    Traina, Tiffany A.
    Rugo, Hope S.
    Dickler, Maura
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2007, 21 (02) : 303 - +
  • [50] Upfront HIPEC and bevacizumab-containing adjuvant chemotherapy in advanced epithelial ovarian cancer
    Paris, Ida
    Cianci, Stefano
    Vizzielli, Giuseppe
    Fagotti, Anna
    Ferrandina, Gabriella
    Alletti, Salvatore Gueli
    Costantini, Barbara
    Cosentino, Francesco
    Capoluongo, Ettore
    Pasqualoni, Mariangela
    Scambia, Giovanni
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2019, 35 (01) : 370 - 374